Impact of Postapproval Evidence Generation on the Biopharmaceutical Industry

Meeting marketplace demands for proving the value of new products requires more data than the industry has routinely produced. These data include evidence from comparative effectiveness research (CER), including randomized, controlled trials; pragmatic clinical trials; observational studies; and meta-analyses.We designed and conducted a survey to examine the industry's perceptions on new data requirements regarding CER evidence, the...